Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colorectal Cancer Screening Cohort Study in Shougang Community Population Based on Polygene Methylation Detection Technology

NCT05485077 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT05485077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05485077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colorectal Cancer Screening Cohort Study in Shougang Community Population Based on Polygene Methylation Detection Technology
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 9, 2022
Completion date
July 9, 2028
Enrollment
18,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer